#MayoClinicRadio podcast: 12/8/18
Listen: Mayo Clinic Radio 12/8/18 On the Mayo Clinic Radio podcast, Dr. John Kisiel, a gastroenterologist at Mayo Clinic, discusses screening, treatment and prevention of colorectal cancer.?Also on the podcast, Dr. Matthew Ferber, a medical geneticist at Mayo Clinic, explains?Mayo Clinic GeneGuide. GeneGuide is the new personal DNA product backed by Mayo medical science and [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 10, 2018 Category: Databases & Libraries Source Type: news
Many Americans Unaware of Promise of Personalized Medicine
THURSDAY, Dec. 6, 2018 -- Medical science has made tremendous advances in personalized medicine. However, the American public is still struggling to understand the implications of these targeted treatments, a new HealthDay/Harris Poll has... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 6, 2018 Category: Pharmaceuticals Source Type: news
Many Americans Unaware of Promise of Targeted,'Personalized' Medicine: Poll
THURSDAY, Dec. 6, 2018 -- Medical science has made tremendous advances in " personalized medicine " -- drugs that fight cancer and other diseases by boosting the immune system or targeting specific genetic traits.
Former U.S. President Jimmy Carter... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 6, 2018 Category: General Medicine Source Type: news
Google taps ex-Geisinger CEO Feinberg to lead consolidated Google Health biz | Personnel Moves – November 14, 2018
Google (NSDQ:GOOG) has picked up former Geisinger Health CEO David Feinberg to lead its fragmented health divisions under the Google Health moniker, according to a recent CNBC report.
The tech giant had been searching for a head for several months, with artificial intelligence head Jeff Dean heavily involved in the process, according to the report. Other candidates include execs from health consulting, hospital management and insurance.
In his new position, Feinberg will work closely with CEO Sundar Pichai, according to CNBC, which references individuals familiar with the search process.
Feinberg will oversee multiple gro...
Source: Mass Device - November 14, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Accuray Inc. Alphabet BioCardia Bovie Medical Corp. Clearside Biomedical Eos Imaging Geisinger Health System Getinge google hancockjaffelabs Intact Vascular Integra LifeSciences Intuitive Surgic Source Type: news
Philanthropist donates $200M towards Harvard biomedical science
A foundation headed by philanthropist Len Blavatnik has given Harvard Medical School its largest gift, $200 million, with the overarching aim of transforming new medical discoveries into patient treatments. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 9, 2018 Category: Pharmaceuticals Source Type: news
Breast milk & babies' saliva shape oral microbiome
(Queensland University of Technology) Newborn breastfed babies' saliva combines with breastmilk to release antibacterial compounds that help to shape the bacterial communities (microbiota) in babies' mouths, biomedical scientists have found. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 8, 2018 Category: International Medicine & Public Health Source Type: news
South Florida health network recruits Newcomer as CEO
South Florida Behavioral Health Network, the managing entity for 39 provider agencies in Miami-Dade and Monroe counties, has named Dr. John W. Newcomer president and CEO.
Newcomer was recruited from Florida Atlantic University, where he was a professor of integrated medical science at the Charles E. Schmidt College of Medicine. Newcomer, who previously worked at the University of Miami and Washington University in St. Louis, has been the principal investigator on m ultiple research projects funded… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 7, 2018 Category: Pharmaceuticals Authors: Brian Bandell Source Type: news
Babylon chatbot could ‘perform worse’ than doctors, review suggests
Private provider Babylon’s chatbot could offer patients a less effective service than a GP, a letter published in medical journal The Lancet has suggested.
In a study published in June, Babylon, which also provides the GP at Hand service to NHS patients, analysed the efficacy of its AI chatbot in primary care triage and diagnosis.
The letter was written by Associate Professor of medical science Hamish Fraser, medical informatics Professor Enrico Coiera and Lecturer in health informatics David Wong. Hide related content:
Show related contentread more (Source: Management in Practice)
Source: Management in Practice - November 7, 2018 Category: Practice Management Authors: vfiore Tags: *** Editor ' s Pick Patient Access Practice development Latest News Source Type: news
Insufficient evidence that Babylon chatbot can perform better than doctors, experts suggest
Private provider Babylon’s chatbot could offer patients a less effective service than a GP, a letter published in medical journal The Lancet has suggested.
In a study published in June, Babylon, which also provides the GP at Hand service to NHS patients, analysed the efficacy of its AI chatbot in primary care triage and diagnosis.
The letter was written by Associate Professor of medical science Hamish Fraser, medical informatics Professor Enrico Coiera and Lecturer in health informatics David Wong. Hide related content:
Show related contentread more (Source: Management in Practice)
Source: Management in Practice - November 7, 2018 Category: Practice Management Authors: vfiore Tags: *** Editor ' s Pick Patient Access Practice development Latest News Source Type: news
Drs. William A. Gahl and Charles N. Rotimi elected into the National Academy of Medicine
The National Academy of Medicine welcomed two NHGRI senior investigators, William A. Gahl, M.D., Ph.D., and Charles N. Rotimi, Ph.D. Recognized as one of the highest honors scientists can receive, members elect new recruits based on their accomplishments in advancing medical science. As a medical geneticist, Dr. Gahl focuses on rare metabolic disorders and the discovery of new genomic diseases. Dr. Rotimi probes the genomic causes of disease and health disparities in a cultural context. (Source: NHGRI Homepage Highlights)
Source: NHGRI Homepage Highlights - October 13, 2018 Category: Genetics & Stem Cells Source Type: news
New Mayo Clinic GeneGuide DNA testing application provides genetic testing, insights backed by Mayo Clinic expertise
ROCHESTER, Minn. ? Mayo Clinic released a new DNA product with Helix, a personal genomics company, called "Mayo Clinic GeneGuide." The DNA-powered product provides healthy individuals with genetic testing and insights with a focus on education. This product is backed by Mayo medical science and expertise. ?The Mayo Clinic GeneGuide app uses the highest quality [...] (Source: Mayo Clinic Business News)
Source: Mayo Clinic Business News - October 1, 2018 Category: Pharmaceuticals Source Type: news
Understanding epilepsy in pediatric tumors
(The Korea Advanced Institute of Science and Technology (KAIST)) A KAIST research team led by Professor Jeong Ho Lee of the Graduate School of Medical Science and Engineering has recently identified a neuronal BRAF somatic mutation that causes intrinsic epileptogenicity in pediatric brain tumors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 18, 2018 Category: International Medicine & Public Health Source Type: news
NAS, NAM Members Receive Prestigious Lasker Awards
The Albert and Mary Lasker Foundation announced today that National Academy of Sciences members Michael Grunstein and C. David Allis share the 2018 Albert Lasker Basic Medical Research Award for discoveries into how gene expression is influenced by the chemical modification of histones— the proteins that package DNA within chromosomes. Joan Argetsinger Steitz, a member of both the NAS and the National Academy of Medicine, is the recipient of the 2018 Lasker~Koshland Special Achievement Award in Medical Science for four decades of leadership in biomedical science— exemplified by pioneering discoveries in RNA bio...
Source: News from the National Academies - September 11, 2018 Category: Science Source Type: news
UCLA ’s Michael Grunstein wins 2018 Lasker Award for medical research
Michael Grunstein, a distinguished professor of biological chemistry at theDavid Geffen School of Medicine at UCLA, has been awarded the 2018 Albert Lasker Basic Medical Research Award for his groundbreaking research on gene expression. He shares the award with C. David Allis of Rockefeller University in New York.Grunstein provided the first demonstration that histones — the proteins that package DNA within chromosomes — are more than inert structures that serve simply as spools for DNA. Working with his team at UCLA, he showed via experiments with yeast that histones actually play an important role in gene expression....
Source: UCLA Newsroom: Health Sciences - September 11, 2018 Category: Universities & Medical Training Source Type: news
2018 Lasker Awards for basic and clinical medical research and special achievement
(Rubenstein Associates, Inc.) The Albert and Mary Lasker Foundation today announced the winners of its 2018 Lasker Awards: C. David Allis from Rockefeller University and Michael Grunstein from the University of California, Los Angeles will receive the Albert Lasker Basic Medical Research Award; John B. Glen, formerly from AstraZeneca, will be honored with the Lasker~DeBakey Clinical Medical Research Award; and Joan Argetsinger Steitz from Yale University will receive the Lasker~Koshland Special Achievement Award in Medical Science. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 11, 2018 Category: Biology Source Type: news
